Prodo Laboratories, Inc.

Aliso Viejo, CA

UEI
GKPKHAN3ZNL4
CAGE
54Y59
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
27402 Aliso Viejo Pkwy, Aliso Viejo, CA 92656, USA
Website
prodolabs.com
Founded
2006
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $23,725
FY2024 $24,375
FY2023 -$22,785

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Grant subawards

Prime recipient Prime award Amount Awarded
Beckman Research Institute Of The City Of Hope The subrecipient will be responsible for the Production and Distribution of Human Islets, Non-Islet Pancreatic Tissue (Acinar), Flash Frozen Islets, and… U24DK098085 $72,800

Similar vendors

About the company

Prodo Laboratories, Inc., located in Aliso Viejo, California, is a for-profit corporate entity registered in SAM.gov that specializes in providing biological materials for medical and genetic research. The company focuses primarily on supplying human islets and related biological specimens to federal research institutions, with a particular emphasis on diabetes and genetic research applications. Registered since July 15, 2008, with an active SAM.gov registration until January 7, 2026, Prodo Laboratories has established itself as a key supplier of specialized research materials to multiple federal agencies.

In terms of federal contract awards, Prodo Laboratories has consistently provided human islets and biological materials through purchase order contracts with agencies such as the National Institute on Aging and the National Human Genome Research Institute. These contracts, typically ranging from $10,285 to $24,375, have been competitively awarded without specific set-aside designations. The contracts predominantly support research initiatives, particularly those focused on genetic analysis of Type 2 diabetes, including population-specific studies like genetic research on the Finnish population. The company has demonstrated a consistent track record of delivering in-vitro diagnostic substances and biological materials through firm fixed-price purchase orders, with contract completion dates spanning from 2021 to 2025.

Regarding federal grant awards, Prodo Laboratories has been involved in sub-grant work, most notably as a subrecipient for the Beckman Research Institute of the City of Hope. In this capacity, the company is responsible for the production and distribution of specialized biological materials, including human islets, non-islet pancreatic tissue (acinar), flash-frozen islets, and histology sections of native pancreas. This sub-grant work, as evidenced by the October 25, 2024 award, further underscores the company's expertise in providing high-quality, research-critical biological specimens to support advanced medical and genetic research initiatives.

SBA capabilities narrative

Human islets for research, diabetes research supplies

Quick answers

Is Prodo Laboratories, Inc. registered in SAM.gov?

Yes. Prodo Laboratories, Inc.'s SAM.gov registration is active through August 3, 2027.

What is Prodo Laboratories, Inc.'s CAGE code?

Prodo Laboratories, Inc.'s CAGE code is 54Y59, and its Unique Entity ID (UEI) is GKPKHAN3ZNL4.

How much has Prodo Laboratories, Inc. received in federal contracts?

Federal contracts obligated $23,725 to Prodo Laboratories, Inc. in fiscal year 2025 and $25,315 in fiscal years 2023 through 2027.

What is Prodo Laboratories, Inc.'s most recent federal award?

Prodo Laboratories, Inc.'s most recent federal contract award is In-vitro diagnostic substance - human islets (75N95D25P00083), from National Institute on Aging (NIH), on September 4, 2025.

On GovTribe

See Prodo Laboratories, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe